Browsing category:


Etanercept, known by the trade name Enbrel, is indicated for reducing the signs and symptoms of Rheumatoid Arthritis. In addition, etanercept, CAS number 185243-69-0, is effective in reduction of symptoms as related to Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Plaque Psoriasis. Developed by researchers at Immunex, etanercept is marketed as Enbrel by[…]

Read More

Bardoxolone Methyl CAS# 218600-53-4, an Antioxidant Inflammation Modulator, is currently in clinical trials as a potential once a day treatment for those patients suffering from Chronic Kidney Disease (CKD). Developed by Reata Pharmaceuticals, Inc. in partnership with Abbott Laboratories and Kyowa Hakko Kirin, this drug will treat people suffering from CKD due to conditions such[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service